ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (0HD2)

100.80
0.00
(0.00%)
Closed 29 November 3:30AM

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.26B1.99B1.57B2.4B3.41B3.64B3.55B3.83B
Total Current Assets 671.88M1.76B1.2B1.72B2.61B2.81B2.69B2.98B
Cash and Equivalents 193.62M645.36M420.15M547.18M496.58M819.98M866.39M812.69M
Total Non-Current Assets 920.22M1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M
Total Liabilities 342.59M228.3M272.84M956.44M2.39B3.06B3.7B4.05B
Total Current Liabilities 131.7M144.25M179.49M352.59M585.27M695.71M767.92M967.79M
Total Non-Current Liabilities 360.89M114.05M123.34M603.85M2B3.04B3.95B4.1B
Total Equity 920.22M1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M
Common Equity 859k997k1.01M1.12M1.16M1.2M1.24M1.26M
Retained Earnings -1.66B-2.15B-2.84B-3.73B-4.59B-5.44B-6.57B-7.01B

Your Recent History

Delayed Upgrade Clock